Nothing Special   »   [go: up one dir, main page]

Forsberg et al., 2016 - Google Patents

Pre‐and probiotics for allergy prevention: time to revisit recommendations?

Forsberg et al., 2016

View PDF
Document ID
5504675138925431128
Author
Forsberg A
West C
Prescott S
Jenmalm M
Publication year
Publication venue
Clinical & Experimental Allergy

External Links

Snippet

Reduced intensity and diversity of microbial exposure is considered a major factor driving abnormal postnatal immune maturation and increasing allergy prevalence, particularly in more affluent regions. Quantitatively, the largest important source of early immune‐microbial …
Continue reading at www.diva-portal.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt

Similar Documents

Publication Publication Date Title
Forsberg et al. Pre‐and probiotics for allergy prevention: time to revisit recommendations?
Jenmalm The mother–offspring dyad: microbial transmission, immune interactions and allergy development
Sestito et al. The role of prebiotics and probiotics in prevention of allergic diseases in infants
West et al. Probiotics during weaning reduce the incidence of eczema
Taylor et al. Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responses
Roessler et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention
Holscher et al. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula‐fed infants: a randomized, double‐blind, controlled trial
Baldassarre et al. Rationale of probiotic supplementation during pregnancy and neonatal period
Senn et al. Microbial colonization from the fetus to early childhood—a comprehensive review
Sanz Gut microbiota and probiotics in maternal and infant health
Schmidt et al. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial
West et al. Bugging allergy; role of pre-, pro-and synbiotics in allergy prevention
Huurre et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double‐blind placebo‐controlled study
Fujimura et al. Role of the gut microbiota in defining human health
Li et al. Early development of the gut microbiome and immune-mediated childhood disorders
Krishnareddy The microbiome in celiac disease
Abrahamsson et al. Gut microbiota and allergy: the importance of the pregnancy period
West et al. Probiotics in primary prevention of allergic disease–follow‐up at 8–9 years of age
Pfefferle et al. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates
Finamore et al. Supplementation with Bifidobacterium longum Bar33 and Lactobacillus helveticus Bar13 mixture improves immunity in elderly humans (over 75 years) and aged mice
Boyle et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial
Muir et al. Microbiome and its impact on gastrointestinal atopy
Ly et al. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity?
Rougé et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial
Vael et al. Early intestinal Bacteroides fragilis colonisation and development of asthma